The Hong Lab (www.thehonglab.org) at Emory University and the Aflac Cancer and Blood Disorders Center is seeking several passionate post-doctoral fellows to tackle translational cancer research projects. The focus will be on:
-identifying novel therapeutics in high-risk childhood cancers such as relapsed Wilms Tumor and the SWI/SNF altered cancers such as Rhabdoid Tumor, ATRT, Renal Medullary Carcinoma and Epitheloid Sarcomas
-understanding mechanisms and expanding our understanding of SMARCB1 biology
We will use functional genomics, high throughput screening, biochemistry and computational biology to address these questions.
The fellow will design and conduct research within cancer epigenetics and biology while receiving advanced training from Andrew Hong, Assistant Professor and Endowed Investigator, to enhance professional skills and research independence needed for pursuit of an academic/industry career. The fellow will Prepares and publishes scientific manuscripts under the direction of the Principal Investigator. May be responsible for operation of specific equipment. May teach techniques to others, train, and supervise research staff. Positions are temporary appointments as a research trainee. The initial appointment is for one year, renewal expected if progress is satisfactory and funds are available. Appointments cannot exceed five years.
MINIMUM QUALIFICATIONS: A doctoral degree or equivalent (Ph.D., M.D., M.D./PhD. or equivalent) in biology or biochemistry. Excellent scientific writing ability and strong oral communication skills. The ability to work effectively and respectfully with colleagues.
Preference given to those with prior experiences either in:
-Applicants who are finishing graduate school or have less than 1 years of postdoctoral experience
-Functional and structural cancer genomics
-Cancer biology and biochemistry
-and/or computational and systems biology